Embed Size (px)
Citation preview
© Copyright 2002 Frost & Sullivan. All Rights Reserved.
U.S. Gene Therapy Markets
Human Genome Research Accelerates Research
“Stringent regulatory requirements will force researchers to undergo rigorous strategic assessments of technologies and clinical
approaches.”
Drug Discovery and Biotechnology Analyst Team
Frost & Sullivan
© Copyright 2002 Frost & Sullivan. All Rights Reserved.
Frost & Sullivan provides:
• Detailed insights into recent developments and trends
• Drivers, restraints, challenges, and strategic recommendations
• Analytical insights on ‘hot topics’ and emerging applications in the gene therapy markets
• Market sizing and competitive analysis
• Market forecasts and opportunity analyses
• Quarterly assessments
• End-user analysis in each report
Key Features
© Copyright 2002 Frost & Sullivan. All Rights Reserved.
• Coverage: The United States
• Proven methodology using extensive primary and secondary data and research
• Focused information and strategies that cover business and technology issues
• Credible data and analysis highlighting industry dynamics
• Precise strategies to help you create winning business plans
What We Offer
© Copyright 2002 Frost & Sullivan. All Rights Reserved.
Current Market Participants• Find out where you stand in comparison with the competitors• Assess current and future drivers and restraints• Determine and exploit new market share opportunities
New Entrants • Analyze challenges associated with the industry• Calculate timescales for strategy implementation• Position yourself to capitalize on the market’s unmet needs
Investment Community• Analyze long-term strategies of companies• Determine which participants will outperform the competition• Assess attractiveness of investing in the market
Benefits
© Copyright 2002 Frost & Sullivan. All Rights Reserved.
Advanced Therapies, Inc.ALZA Corp.ARIAD Pharmaceuticals, Inc.Athersys, Inc.Aventis GencellAvigen, Inc.BD Biosciences ClontechBio-Rad Laboratories, Inc.BioStratum, Inc.Biovector Therapeutics, S.A.Cell Gensys, Inc.Dendritech, Inc.Enzo Biochem, Inc.F.H.Faulding & Co LtdGenelabs Technologies, Inc.Genetic Therapy, Inc.Genetix Pharmaceuticals, Inc.Genetronics Biomedical Ltd.GenStar Therapeutics Corp.
GenVec, Inc.Glygen Corp.Immune Response Corp.InexIntronn LLCInvivoGenLexicon Genetics, Inc.Nature Technology Corp.Onyx Pharmaceuticals, Inc.Polygenetics, Inc.REPLICor Inc.RHeoGeneRibozyme Pharmaceutical, Inc.Selective GeneticsStem Cells, Inc.StressGenTargeted Genetics Corp.Therion Biologics Corp.Valentis, Inc.ValiGen, Inc.
Key Market Participants
© Copyright 2002 Frost & Sullivan. All Rights Reserved.
• Call toll free 877 GO FROST
(877.463.7876)
• Fax toll free 888.690.3329
• E-mail [email protected]
• Visit www.frost.com
For More Information
